0001388658-20-000258.txt : 20201008
0001388658-20-000258.hdr.sgml : 20201008
20201008155930
ACCESSION NUMBER: 0001388658-20-000258
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20201006
FILED AS OF DATE: 20201008
DATE AS OF CHANGE: 20201008
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: King Kevin M
CENTRAL INDEX KEY: 0001385014
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37918
FILM NUMBER: 201231017
MAIL ADDRESS:
STREET 1: C/O AFFYMETRIX, INC.
STREET 2: 3420 CENTRAL EXPRESSWAY
CITY: SANTA CLARA
STATE: CA
ZIP: 95051
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: iRhythm Technologies, Inc.
CENTRAL INDEX KEY: 0001388658
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 208149544
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 650 TOWNSEND STREET
STREET 2: SUITE 500
CITY: San Francisco
STATE: CA
ZIP: 94103
BUSINESS PHONE: 415-632-5700
MAIL ADDRESS:
STREET 1: 650 TOWNSEND STREET
STREET 2: SUITE 500
CITY: San Francisco
STATE: CA
ZIP: 94103
FORMER COMPANY:
FORMER CONFORMED NAME: IRhythm Technologies, Inc.
DATE OF NAME CHANGE: 20110429
FORMER COMPANY:
FORMER CONFORMED NAME: IRhythm Technologies Inc
DATE OF NAME CHANGE: 20070201
4
1
wf-form4_160218715608724.xml
FORM 4
X0306
4
2020-10-06
0
0001388658
iRhythm Technologies, Inc.
IRTC
0001385014
King Kevin M
C/O IRHYTHM TECHNOLOGIES, INC.
699 8TH ST # 600
SAN FRANCISCO
CA
94103
0
1
0
0
President and CEO
Common Stock
2020-10-06
4
M
0
5882
17
A
235652
D
Common Stock
2020-10-06
4
M
0
6449
8.18
A
242101
D
Employee Stock Option (right to buy)
17.0
2020-10-06
4
M
0
5882
0
D
2017-09-21
2026-10-19
Common Stock
5882.0
17918
D
Employee Stock Option (right to buy)
8.18
2020-10-06
4
M
0
6449
0
D
2019-12-15
2025-12-15
Common Stock
6449.0
1959
D
The option, originally granted for 81,595 shares, of which 63,677 shares have been exercised, vested as to 1/4 of the shares on September 21, 2017 and as to 1/36 of the remaining shares each month thereafter.
All of the shares subject to this option are fully vested and exercisable as of the date hereof.
Christina Delfin, attorney in fact
2020-10-08